Citadel Advisors - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 4 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of NOVAVAX INC
ValueSharesWeighting
Q1 2019$3,595,000
+10.9%
6,525,547
+270.3%
0.00%
+100.0%
Q4 2018$3,243,000
+99.8%
1,762,320
+104.2%
0.00%
Q3 2018$1,623,000
+91.4%
863,019
+36.4%
0.00%
Q2 2018$848,000
+8.6%
632,773
+70.1%
0.00%
Q1 2018$781,000
-62.2%
371,898
-77.7%
0.00%
-100.0%
Q4 2017$2,068,000
+418.3%
1,667,701
+377.5%
0.00%
Q3 2017$399,000
-40.5%
349,259
-40.1%
0.00%
Q2 2017$671,000
+90.6%
582,946
+111.5%
0.00%
Q1 2017$352,000
-34.9%
275,680
-35.8%
0.00%
Q4 2016$541,000
-84.8%
429,276
-75.0%
0.00%
-100.0%
Q3 2016$3,568,000
+1156.3%
1,715,540
+4292.2%
0.00%
Q2 2016$284,000
+51.1%
39,059
+7.0%
0.00%
Q1 2016$188,000
-99.0%
36,505
-98.4%
0.00%
-100.0%
Q4 2015$19,308,000
+325.3%
2,301,386
+258.4%
0.02%
+425.0%
Q3 2015$4,540,000
-5.9%
642,133
+48.3%
0.00%0.0%
Q2 2015$4,823,000
+465.4%
432,935
+320.0%
0.00%
+300.0%
Q1 2015$853,000
+152.4%
103,092
+80.6%
0.00%
Q4 2014$338,000
+42.0%
57,076
-0.1%
0.00%
Q3 2014$238,000
-5.2%
57,105
+5.0%
0.00%
Q2 2014$251,000
-81.9%
54,387
-82.2%
0.00%
-100.0%
Q1 2014$1,387,000
+211.7%
306,255
+251.9%
0.00%
+100.0%
Q4 2013$445,000
+888.9%
87,041
+505.1%
0.00%
Q3 2013$45,000
+7.1%
14,384
-30.3%
0.00%
Q2 2013$42,00020,6410.00%
Other shareholders
NOVAVAX INC shareholders Q2 2019
NameSharesValueWeighting ↓
Caption Management, LLC 2,021,600$22,273,0001.23%
GREAT POINT PARTNERS LLC 4,500,000$2,479,0000.24%
SABBY MANAGEMENT, LLC 860,000$474,0000.23%
Sargent Investment Group, LLC 588,070$324,0000.16%
BB BIOTECH AG 8,330,000$4,589,0000.12%
GREAT POINT PARTNERS LLC 2,000,000$1,102,0000.11%
CENTAURUS FINANCIAL, INC. 7$12,000,0000.07%
Rock Springs Capital Management LP 3,250,000$1,790,0000.07%
Beirne Wealth Consulting Services, LLC 155,000$85,0000.07%
ACUTA CAPITAL PARTNERS, LLC 250,000$138,0000.07%
View complete list of NOVAVAX INC shareholders